Status:
COMPLETED
Atorvastatin in Acute Stroke Treatment
Lead Sponsor:
University of Palermo
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Recent clinical trials and meta-analyses of b-hydroxy-bmethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have demonstrated a significant reduction in ischemic stroke in patients with ...
Detailed Description
Material and Methods The investigators will enroll patients with a diagnosis of acute ischemic stroke admitted to the Internal Medicine Department at the University of Palermo between November 2011 an...
Eligibility Criteria
Inclusion
- Eligible patients were men and women over 18 years of age who had an acute ischemic stroke with a symptom time onset \< 48 hours
Exclusion
- Patients with inflammatory or infectious diseases, cancer, hematological diseases and severe renal or liver failure, as well as those who were under treatment with anti-inflammatory were excluded
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02225834
Start Date
November 1 2011
End Date
March 1 2014
Last Update
August 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internal Medicine Ward, University of Palermo
Palermo, Italy, Italy, 90127